Cardiovascular devices are used in treating diseases related to the heart and the circulatory system. Transcatheter mitral valve repair (TMVR) devices are used for minimally invasive treatment of mitral regurgitation (MR). GlobalData uses proprietary data and analytics to provide a comprehensive report on the transcatheter mitral valve implantation market in Ireland. Buy the latest report here.
In 2022, GlobalData’s Market Model methodology determined that the leading player in the transcatheter mitral valve implantation market in Ireland was and Abbott Laboratories.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Since traditional open surgery is not required, patients receiving a TMVR are usually able go home the next day and are able to resume their daily activities. A minimally invasive approach improves patient outcomes, reduces recovery times and lowers readmission rates.
The transcatheter mitral valve implantation market in Ireland can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size transcatheter mitral valve implantation in Ireland, buy the report here.